Table 1.
Characteristics of patients treated for extrapulmonary tuberculosis
| 2009 (n = 399) | 2013 (n = 336) | P-value | |
|---|---|---|---|
| Agea | |||
| ⩽18 years | 26 (7) | 41 (12) | P < 0·01 |
| >18 years | 373 (93) | 295 (88) | |
| Gendera | |||
| Male | 189 (47) | 150 (45) | P = 0·48b |
| Female | 210 (53) | 185 (55) | |
| HIV-infectiona | |||
| HIV-infected | 267 (82) | 224 (70) |
P < 0·01c
P < 0·01d |
| HIV-uninfected | 57 (18) | 94 (30) | |
| Unknown | 75 | 18 | |
| HIV-infected individuals on ARTa | |||
| Yes | 63 (25) | 123 (57) | P < 0·01e |
| No | 192 (75) | 94 (43) | |
| Median CD4 of HIV-infected patients at diagnosis of EPTBf | |||
| On ART | 117 (16–362) | 103 (4–725) | |
| Not on ART | 127 (3–845) | 123 (1–1149) | |
HIV, human immunodeficiency virus; ART, antiretroviral therapy.
a
Data are shown as number (%).
b
P-value is given for male vs. female.
c
P-value is given for HIV-infected vs. HIV-uninfected.
d
P-value is given for known HIV-status vs. unknown HIV-status.
e
P-value is given for Yes vs. No.
f
Data are shown as median (minimum–maximum) in cells/mm3.